Carador Income Fund (CIFU LN) Strong primary and secondary market CLO activity | Future (FUTR LN) Delivering monetisation for investors | Horizon Discovery Group (HZD LN) New gene editing platform broadens capability; reiterate Buy | Midatech Pharma (MTPH LN) Lead candidate selected in glioma programme | Restore (RST LN) Positive start to 2017, lifting Target Price to 470p | StatPro Group (SOG LN) Trading in Q1 in line with expectations | Vectura Group (VEC LN) Positive Phase I VR942 data to be ....
22 May 2017
N+1 Singer - Morning Song 22-05-2017
Restore, 492 | Horizon Discovery Group, 150 | Midatech Pharma, 3.4 | Statpro Group, 0 | Future, 1,532 | Vectura Group, 90.7 | Carador Income Fund, 45.0
-
-
-
N+1 Singer Team
-
14 pages
-
